Watch Ticker

Nkarta, Inc. Common Stock

Go to Nkarta, Inc. Common Stock Website

$2.08

-0.04 (-1.89%)

Live

Previous Close

$2.07

Day Range

$2.04 - $2.1299

Previous Day Range

$2.06 - $2.165

Market Cap

$150.4 million USD

Day Vol.

264703

Previous Day Vol.

210297

Currency

USD

Primary Exchange

Nasdaq

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Nkarta to Participate in an April Investor Conference

Nkarta, Inc., a biopharmaceutical company developing engineered natural killer (NK) cell therapies, announced its participation in the 24th Annual Needham Virtual Healthcare Conference on April 8, 2025.

Related tickers: NKTX.

Read Full Article

N/A - Nkarta to Participate in an Upcoming Investor Conference

Nkarta, Inc., a biopharmaceutical company developing engineered natural killer (NK) cell therapies, announced its participation in the 7th Annual Evercore HealthCONx Conference on December 4, 2024.

Related tickers: NKTX.

Read Full Article

Trending Tickers

Please sign in to view